Akira Kazama

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer

Hiroo Kuroki, Tsutomu Anraku, Akira Kazama et al. · Scientific Reports · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma

Akira Kazama, Tsutomu Anraku, Hiroo Kuroki et al. · Oncology Reports · 2021 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Functional recovery after partial nephrectomy in a solitary kidney

Worapat Attawettayanon, Yosuke Yasuda, JJ H. Zhang et al. · Urologic Oncology Seminars and Original Investigations · 2023 · 19 citations

Medicine, Surgery, Functional Restoration +11

Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer

Tsutomu Anraku, Hiroo Kuroki, Akira Kazama et al. · International Journal of Molecular Medicine · 2019 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15

Parenchymal volume preservation during partial nephrectomy: improved methodology to assess impact and predictive factors

Akira Kazama, Worapat Attawettayanon, Carlos Muñoz-López et al. · British Journal of Urology · 2024 · 16 citations · Full text

Medicine, Surgery, Urology +17